Physician profile
Jacques Khoury
NPI 1427025360
$2,286.33
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,838 · 2020: $448.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $476.21 | 2019-2020 | |
| Abbvie INC. | $444.51 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $390.39 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $176.67 | 2019-2020 | |
| Gilead Sciences, INC. | $158.40 | 2019-2020 | |
| Shire North American Group INC | $101.30 | 2019 | |
| Ucb, INC. | $99.94 | 2019-2020 | |
| Intercept Pharmaceuticals, INC. | $74.43 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $68.95 | 2019 | |
| Janssen Biotech, INC. | $58.41 | 2019 | |
| Braintree Laboratories, INC. | $54.26 | 2019 | |
| Allergan, INC. | $40.86 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $30.73 | 2019 | |
| Ironwood Pharmaceuticals, INC | $28.90 | 2019-2020 | |
| Pfizer INC. | $25.95 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Qol Medical, LLC | $22.09 | 2019 | |
| Amgen INC. | $22.07 | 2020 | |
| Alfasigma USA, INC. | $12.26 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacques Khoury listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.